Pharmaceutical Preparations · DE · CIK 2022626
Developing treatments for inflammatory diseases, focusing on severe respiratory disorders by targeting the TSLP receptor
Comparable business profile · signals at a glance
In the 90 days to Mar 16, 2026: 5 sold $47K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Sutherland Everett RandChief Executive Officer | Sell | 2,093 | $9.29 | $19K |
| Mar 16, 2026 | Deykin AaronChief Medical Officer | Sell | 894 | $9.29 | $8K |
| Mar 16, 2026 | Gray MichaelCFO and COO | Sell | 852 | $9.29 | $8K |
| Mar 16, 2026 | Houghton AdamChief Business Officer | Sell | 699 | $9.29 | $6K |
| Mar 16, 2026 | Ambrose AllisonGeneral Counsel | Sell | 475 | $9.29 | $4K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.